vs
MYOMO, INC.（MYO）与High Roller Technologies, Inc.（ROLR）财务数据对比。点击上方公司名可切换其他公司
MYOMO, INC.的季度营收约是High Roller Technologies, Inc.的1.8倍（$11.4M vs $6.3M），High Roller Technologies, Inc.净利率更高（58.4% vs -33.6%，领先92.0%），MYOMO, INC.同比增速更快（-5.9% vs -16.4%），High Roller Technologies, Inc.自由现金流更多（$-90.0K vs $-2.4M）
MYOMO INC.是一家医疗科技企业，研发和生产可穿戴肌电矫形设备，帮助上肢瘫痪或无力的患者恢复肢体活动能力，核心产品面向中风、脊髓损伤及其他神经系统疾病患者，主要市场覆盖北美地区。
该企业主营游乐设施业务，凭借气动驱动技术打造各类游乐设备，专业从事过山车设计研发，在游乐设施设计制造领域拥有相关技术积累与行业经验。
MYO vs ROLR — 直观对比
营收规模更大
MYO
是对方的1.8倍
$6.3M
营收增速更快
MYO
高出10.5%
-16.4%
净利率更高
ROLR
高出92.0%
-33.6%
自由现金流更多
ROLR
多$2.3M
$-2.4M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.4M | $6.3M |
| 净利润 | $-3.8M | $3.7M |
| 毛利率 | 68.6% | — |
| 营业利润率 | -24.4% | 1.3% |
| 净利率 | -33.6% | 58.4% |
| 营收同比 | -5.9% | -16.4% |
| 净利润同比 | -1366.4% | 831.9% |
| 每股收益（稀释后） | $-0.09 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MYOROLR
| Q4 25 | $11.4M | — | ||
| Q3 25 | $10.1M | $6.3M | ||
| Q2 25 | $9.7M | $6.9M | ||
| Q1 25 | $9.8M | $6.8M | ||
| Q4 24 | $12.1M | — | ||
| Q3 24 | $9.2M | $7.5M | ||
| Q2 24 | $7.5M | — | ||
| Q1 24 | $3.8M | — |
净利润MYOROLR
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-3.7M | $3.7M | ||
| Q2 25 | $-4.6M | $-592.0K | ||
| Q1 25 | $-3.5M | $-3.3M | ||
| Q4 24 | $-260.1K | — | ||
| Q3 24 | $-966.4K | $-501.0K | ||
| Q2 24 | $-1.1M | — | ||
| Q1 24 | $-3.8M | — |
毛利率MYOROLR
| Q4 25 | 68.6% | — | ||
| Q3 25 | 63.8% | — | ||
| Q2 25 | 62.7% | — | ||
| Q1 25 | 67.2% | — | ||
| Q4 24 | 71.4% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 70.8% | — | ||
| Q1 24 | 61.2% | — |
营业利润率MYOROLR
| Q4 25 | -24.4% | — | ||
| Q3 25 | -34.9% | 1.3% | ||
| Q2 25 | -47.6% | -7.2% | ||
| Q1 25 | -35.8% | -47.4% | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | -10.4% | -6.3% | ||
| Q2 24 | -14.8% | — | ||
| Q1 24 | -103.6% | — |
净利率MYOROLR
| Q4 25 | -33.6% | — | ||
| Q3 25 | -36.3% | 58.4% | ||
| Q2 25 | -48.0% | -8.5% | ||
| Q1 25 | -35.2% | -48.4% | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | -10.5% | -6.7% | ||
| Q2 24 | -14.9% | — | ||
| Q1 24 | -102.2% | — |
每股收益（稀释后）MYOROLR
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.09 | $0.39 | ||
| Q2 25 | $-0.11 | $-0.07 | ||
| Q1 25 | $-0.08 | $-0.39 | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $-0.03 | $-0.07 | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.4M | $2.7M |
| 总债务越低越好 | $11.2M | — |
| 股东权益账面价值 | $11.4M | $6.6M |
| 总资产 | $38.6M | $16.0M |
| 负债/权益比越低杠杆越低 | 0.98× | — |
8季度趋势，按日历期对齐
现金及短期投资MYOROLR
| Q4 25 | $18.4M | — | ||
| Q3 25 | $12.6M | $2.7M | ||
| Q2 25 | $15.5M | $2.7M | ||
| Q1 25 | $21.5M | $3.5M | ||
| Q4 24 | $24.9M | — | ||
| Q3 24 | $6.6M | $1.3M | ||
| Q2 24 | $9.0M | — | ||
| Q1 24 | $11.0M | — |
总债务MYOROLR
| Q4 25 | $11.2M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $1.3M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MYOROLR
| Q4 25 | $11.4M | — | ||
| Q3 25 | $14.6M | $6.6M | ||
| Q2 25 | $17.6M | $2.6M | ||
| Q1 25 | $21.7M | $2.8M | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $9.3M | $-779.0K | ||
| Q2 24 | $9.7M | — | ||
| Q1 24 | $10.9M | — |
总资产MYOROLR
| Q4 25 | $38.6M | — | ||
| Q3 25 | $34.1M | $16.0M | ||
| Q2 25 | $38.7M | $12.3M | ||
| Q1 25 | $40.9M | $12.8M | ||
| Q4 24 | $42.2M | — | ||
| Q3 24 | $16.3M | $12.9M | ||
| Q2 24 | $16.2M | — | ||
| Q1 24 | $16.5M | — |
负债/权益比MYOROLR
| Q4 25 | 0.98× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.1M | $-78.0K |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $-90.0K |
| 自由现金流率自由现金流/营收 | -21.0% | -1.4% |
| 资本支出强度资本支出/营收 | 10.9% | 0.2% |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | $-18.7M | — |
8季度趋势，按日历期对齐
经营现金流MYOROLR
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $-1.8M | $-78.0K | ||
| Q2 25 | $-8.9M | $-840.0K | ||
| Q1 25 | $-2.7M | $-3.6M | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $-1.5M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-3.2M | — |
自由现金流MYOROLR
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-2.9M | $-90.0K | ||
| Q2 25 | $-10.1M | $-845.0K | ||
| Q1 25 | $-3.3M | $-3.6M | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $-1.8M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-3.3M | — |
自由现金流率MYOROLR
| Q4 25 | -21.0% | — | ||
| Q3 25 | -28.6% | -1.4% | ||
| Q2 25 | -104.9% | -12.2% | ||
| Q1 25 | -34.0% | -53.5% | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | -19.7% | — | ||
| Q2 24 | -27.1% | — | ||
| Q1 24 | -88.0% | — |
资本支出强度MYOROLR
| Q4 25 | 10.9% | — | ||
| Q3 25 | 10.4% | 0.2% | ||
| Q2 25 | 13.0% | 0.1% | ||
| Q1 25 | 6.8% | 0.2% | ||
| Q4 24 | 7.1% | — | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.6% | — |
现金转化率MYOROLR
| Q4 25 | — | — | ||
| Q3 25 | — | -0.02× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MYO
| Direct To Patient | $7.9M | 69% |
| Clinical And Medical Providers | $3.5M | 31% |
ROLR
| Net Gaming Revenue | $4.9M | 77% |
| Net Revenue Noncore Services | $1.4M | 23% |
